Real-World Outcomes of Initiating Injectable Therapy With Insulin Glargine or Liraglutide Among Patients With Type 2 Diabetes

被引：0
|
作者：
Levin, Philip
Wei, Wenhui
Vlajnic, Aleksandra
Pan, Chunshen
Xie, Lin
Lin, Jay
Baser, Onur
机构：
来源：
DIABETES | 2012年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
11-OR
引用
收藏
页码：A4 / A4
页数：1
相关论文
共 50 条
  • [1] The INITIATOR study: real-world treatment patterns and outcomes in patients with type 2 diabetes initiating insulin glargine or liraglutide
    Levin, P. A.
    Wei, W.
    Buysman, E.
    Thayer, S.
    Brekke, L.
    Crown, W. H.
    Grabner, M.
    Ke, X.
    Quimbo, R. A.
    Cziraky, M. J.
    Hu, W.
    Cuddihy, R.
    Chu, J. W.
    [J]. DIABETOLOGIA, 2014, 57 : S53 - S54
  • [2] Real-world characteristics of patients with type 2 diabetes initiating insulin glargine plus exenatide or insulin glargine plus liraglutide
    Di Genio, A.
    Ling, Z.
    Davis, K. L.
    Meyers, J. L.
    Dalal, M. R.
    [J]. DIABETOLOGIA, 2012, 55 : S328 - S328
  • [3] REAL-WORLD PRACTICE PATTERNS, CLINICAL AND ECONOMIC OUTCOMES AMONG US PATIENTS WITH TYPE 2 DIABETES INITIATING ONCE-DAILY INJECTABLE PEN THERAPY WITH INSULIN GLARGINE OR LIRAGLUTIDE
    Raparla, Swetha
    Wei, Wenhui
    Grabner, Michael
    Cuddihy, Robert M.
    Hu, Wenli
    Quimbo, Ralph
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2012, 27 : S293 - S293
  • [4] Combination therapy with insulin glargine and exenatide: real-world outcomes in patients with type 2 diabetes
    Levin, Philip
    Wei, Wenhui
    Wang, Li
    Pan, Chunshen
    Douglas, Damon
    Baser, Onur
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (03) : 439 - 446
  • [5] Real-World Practice Pattern and Outcomes of Patients With Type 2 Diabetes (T2DM) Initiating Injectable Therapy via Insulin Glargine Disposable Pen (GLA-P) or Liraglutide (LIRA)
    Lin, Jay
    Wei, Wenhui
    Vlajnic, Aleksandra
    Pan, Chunshen
    Xie, Lin
    Baser, Onur
    Levin, Philip
    [J]. DIABETES, 2012, 61 : A286 - A286
  • [6] Real-world comparative outcomes of US type 2 diabetes patients initiating analog basal insulin therapy
    Davis, Keith L.
    Tangirala, Muralikrishna
    Meyers, Juliana L.
    Wei, Wenhui
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2013, 29 (09) : 1083 - 1091
  • [7] REAL-WORLD TREATMENT PATTERNS AND OUTCOMES WHEN INITIATING ONCE-DAILY INJECTABLE PEN THERAPY WITH INSULIN GLARGINE OR LIRAGLUTIDE - AN ELECTRONIC MEDICAL RECORDS STUDY
    Mersey, J.
    Wei, W.
    Meyers, J.
    Wang, C. C.
    Dalal, M. R.
    Bromberger, L. A.
    Levin, P.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A494 - A494
  • [8] REAL-WORLD' CLINICAL OUTCOMES OF EXENATIDE BID COMPARED TO INSULIN GLARGINE IN PATIENTS WITH TYPE 2 DIABETES
    Pawaskar, M.
    Li, Q.
    Hoogwerf, B.
    Reynolds, M. W.
    Faries, D. E.
    Bruhn, D.
    Bergenstal, R.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A475 - A475
  • [9] The INITIATOR Study: Pilot Data on Real-World Clinical and Economic Outcomes in US Patients with Type 2 Diabetes Initiating Injectable Therapy
    Thayer, Sarah
    Wei, Wenhui
    Buysman, Erin
    Brekke, Lee
    Crown, William
    Grabner, Michael
    Raparla, Swetha
    Quimbo, Ralph
    Cziraky, Mark J.
    Hu, Wenli
    Cuddihy, Robert
    [J]. ADVANCES IN THERAPY, 2013, 30 (12) : 1128 - 1140
  • [10] The INITIATOR Study: Pilot Data on Real-World Clinical and Economic Outcomes in US Patients with Type 2 Diabetes Initiating Injectable Therapy
    Sarah Thayer
    Wenhui Wei
    Erin Buysman
    Lee Brekke
    William Crown
    Michael Grabner
    Swetha Raparla
    Ralph Quimbo
    Mark J. Cziraky
    Wenli Hu
    Robert Cuddihy
    [J]. Advances in Therapy, 2013, 30 : 1128 - 1140
12345